Verona (VRNA) Talks Up The Long View Following Phase II Setback
Verona Pharma (NASDAQ:VRNA) highlighted a surprising benefit from a lower [...]
Verona Pharma (NASDAQ:VRNA) highlighted a surprising benefit from a lower [...]
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) reported impressive results on December 1, 2018 [...]
Last week, Galmed Pharmaceuticals (NASDAQ:GLMD) shares climbed as high as [...]
Eidos Therapeutics, Inc. (NASDAQ:EIDX) shares are up as much as [...]
November Catalyst: Aramchol SanaCurrents forecasts an advantageous probability Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) [...]
4Q Catalyst: AG10 phase II data Based on its analytics [...]
Because FDA marketing clearance to sell a drug or device [...]
Introducing SanaCurrents Introducing SanaCurrents, a research service for the serious [...]